Riot Platforms Surges to New 52Week High Tapping 2593 Tulsi Gabbard Steps Down as Intelligence Chief to Focus on Family Health Potential SpaceX IPO Could Join Historys Largest Stock Market Debuts Singapore Core Inflation Sees Surprise Drop in April but Looming Energy Costs Pose Risks Elon Musks Legal Setback Against OpenAI Why the Litigation Strategy May Continue GitHub Outages and Rival Tools Challenge Microsofts AI Coding Ambitions EZRA Q1 2023 Earnings Massive EPS Surprise of 324 Against Negative Estimate Revenue Unreported Nuburu Inc BURU Q3 2023 Earnings Net Loss Reported as Company Advances Industrial Laser Commercialization ACXP Q1 2026 Earnings Narrowed Loss Surprises as Acurx Advances Lead Candidate SLGL Q4 2025 Earnings EPS Misses Estimates as DevelopmentStage Biotech Reports No Revenue Liberty Live Holdings Inc Series A LLYVA Q4 2025 Earnings EPS Falls Just Short of Estimates Stock Slightly Lower United Parks Resorts PRKS Q1 2026 Earnings WiderThanExpected Loss Fails to Dampen Investor Sentiment PDF Solutions Surges 339 as Shares Approach Key Resistance Level SPACSphere Acquisition Corp SSAC Holds Steady at 995 Testing Key Technical Juncture Daedalus Special Acquisition Corp Warrants DSACW Remain Flat at 045 as Market Awaits Catalysts Community Health Systems CYH Faces Renewed Selling Pressure Tests Key Support Genius Sports GENI Edges Higher as Stock Holds Above Key Support Scienture Holdings Inc SCNX Q1 2026 Earnings Significant EPS Beat Highlights Cost Discipline and Operational Progress ANIP Q1 2026 Earnings EPS Surges 54 Above Estimates Driving Strong Performance Nutriband NTRB Q1 2026 Earnings Large EPS Beat on Minimal Loss vs Deeply Negative Consensus BNED Q4 2025 Earnings NarrowerThanExpected Loss Drives Stock Rally TRVI Q1 2026 Earnings ClinicalStage Biotech Reports WiderThanExpected Loss Shares Edge Higher Coeur Mining Q1 2026 Earnings EPS Misses Expectations Stock Slightly Negative Nifty 50 Sensex Likely to Open Lower on May 27 as Gift Nifty Signals Weakness GLDG Q1 2026 Earnings NarrowerThanExpected Loss Reflects Cost Discipline in PreRevenue Stage Fractyl Health GUTS Dips Near Key Support After 662 Decline Biotech Volatility Continues